Clonidine infusion increases uptake of 99mTc-Exametazime in anterior cingulate cortex in Korsakoff's psychosis.
The effects upon regional brain function of infusing either saline or clonidine (1.5 microgram/kg) has been examined in 18 patients with alcoholic Korsakoff's psychosis using 99mTc-hexamethylpropyleneamineoxime (99mTc-HMPAO or 99mTc-Exametazime) and Single Photon Emission Tomography (SPET or SPECT). The hypothesis tested was that frontal lobe function would be increased by adrenoceptor stimulation. This was confirmed by an increase in the uptake of 99mTc-Exametazime into anterior cingulate regions of the frontal lobes. Patients were scanned before and after saline or clonidine infusion during performance of a verbal fluency task. There was a significantly increased performance of verbal fluency in patients given clonidine. This effect was variable and could not be unequivocably distinguished from increases in performance in the saline treated group. Nevertheless, the increase in neuropsychological performance was also correlated with increased function in left dorsolateral frontal cortex within the clonidine treated group. An exploratory examination of other brain areas suggested that relative increases in posterior cingulate cortex and changes in the symmetry of function within the thalamus may also be produced by acute infusion of clonidine in Korsakoff patients. The findings support the idea that adrenergic mechanisms may modulate cognitive performance by actions on attentional systems within the brain. These appear to be located primarily within limbic cortex. It is, of course, notable that this can occur in patients with profound and disabling amnesia.
Moffoot
A
A
MRC Brain Metabolism Unit, Royal Edinburgh Hospital.
O'Carroll
R E
RE
Murray
C
C
Dougall
N
N
Ebmeier
K
K
Goodwin
G M
GM
D000328:Adult; D000368:Aged; D000425:Alcohol Amnestic Disorder / Q000150:complications / Q000175:diagnosis* / Q000378:metabolism; D002560:Cerebrovascular Circulation; D003000:Clonidine / Q000494:pharmacology*; D003072:Cognition Disorders / Q000175:diagnosis / Q000209:etiology; D005625:Frontal Lobe / Q000000981:diagnostic imaging / Q000187:drug effects / Q000378:metabolism; D006179:Gyrus Cinguli / Q000000981:diagnostic imaging / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D011941:Receptors, Adrenergic / Q000187:drug effects; D016037:Single-Blind Method; D012965:Sodium Chloride / Q000494:pharmacology*; D017556:Technetium Compounds / Q000493:pharmacokinetics; D015899:Tomography, Emission-Computed, Single-Photon; D014705:Verbal Behavior / Q000187:drug effects
D011941:Receptors, Adrenergic; D017556:Technetium Compounds; D012965:Sodium Chloride; D003000:Clonidine